Arbe Robotics CTO granted 185K shares, sells 337K

Arbe Robotics’ CTO received a large restricted share grant while selling shares under a pre-arranged Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

Arbe Robotics Ltd. (ARBE) reported insider activity by Chief Technology Officer and director Noam Arkind. On September 9, 2026, he received a grant of 185,000 restricted ordinary shares that vest in full on April 1, 2027, subject to continued service, bringing his directly held restricted shares to 1,408,982. The award was approved by the board on April 22, 2026 and by shareholders at the annual meeting on September 9, 2026. In addition, Arkind sold an aggregate 337,300 ordinary shares between September 3 and 8, 2026 at prices between $0.6294 and $0.7796 per share under a Rule 10b5-1 trading plan adopted on March 4, 2026.

Insider Trade Summary 10b5-1

Net Seller: 337,300 shares

Net Sell 4 txns

Insider Arkind Noam

Role Chief Technology Officer

Sold 337,300 shs ($254K)

Type	Security	Shares	Price	Value
Grant/Award	Restricted Shares F1	185,000	$0.00	$0.00
Sale	Ordinary Shares F2	278,800	$0.7796	$217K
Sale	Ordinary Shares F2	22,700	$0.6294	$14K
Sale	Ordinary Shares F2	35,800	$0.6321	$23K

Holdings After Transaction: Ordinary Shares — 1,223,982 shares (Direct); Restricted Shares — 1,408,982 shares (Direct)

Footnotes (2)

1. F1. The reported securities are restricted ordinary shares granted under the Company's equity incentive plan. The shares vest in full on April 1, 2027, subject to the reporting person's continued service through the vesting date, and are subject to forfeiture until vesting. The award was approved by the Board on April 22, 2026, subject to shareholder approval, and was approved by the Company's shareholders at the annual general meeting held on September9, 2026.
2. F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2026.

Key Figures

Restricted shares granted: 185,000 shares Restricted shares held after grant: 1,408,982 shares Shares sold: 337,300 shares +5 more

8 metrics

Restricted shares granted 185,000 shares Grant to CTO on September 9, 2026

Restricted shares held after grant 1,408,982 shares Direct restricted ordinary share holdings after September 9, 2026 grant

Shares sold 337,300 shares Ordinary shares sold by CTO between September 3–8, 2026

Sale price September 3, 2026 $0.6321 per share Sale of 35,800 ordinary shares

Sale price September 4, 2026 $0.6294 per share Sale of 22,700 ordinary shares

Sale price September 8, 2026 $0.7796 per share Sale of 278,800 ordinary shares

Vesting date April 1, 2027 Full vesting date for 185,000 restricted shares

Rule 10b5-1 plan adoption date March 4, 2026 Plan under which reported sales were effected

Key Terms

Restricted Shares, equity incentive plan, Rule 10b5-1 trading plan

3 terms

Restricted Shares financial

"The reported securities are restricted ordinary shares granted under the Company's equity"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

equity incentive plan financial

"restricted ordinary shares granted under the Company's equity incentive plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did ARBE’s CTO report in this Form 4?

The CTO, Noam Arkind, reported a grant of 185,000 restricted ordinary shares on September 9, 2026 and sales totaling 337,300 ordinary shares between September 3 and 8, 2026 at prices from $0.6294 to $0.7796 per share.

How many Arbe Robotics (ARBE) shares does the CTO hold after the new grant?

Following the September 9, 2026 restricted share grant, the CTO directly holds 1,408,982 restricted ordinary shares, which remain subject to vesting and forfeiture conditions described in the award terms.

When do the newly granted ARBE restricted shares vest?

The 185,000 restricted ordinary shares granted to the CTO vest in full on April 1, 2027, provided he continues to serve through that vesting date; the shares are subject to forfeiture until vesting.

Were the ARBE share sales under a Rule 10b5-1 trading plan?

Yes. The filing states that the sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the CTO on March 4, 2026, and the Rule 10b5-1 checkbox for the transactions is affirmed.

What prices did the ARBE insider share sales occur at?

The CTO sold 337,300 ordinary shares of Arbe Robotics at per-share prices of $0.6321 on September 3, 2026, $0.6294 on September 4, 2026, and $0.7796 on September 8, 2026, according to the Form 4 data.

How was the ARBE restricted share grant approved?

The filing states the restricted ordinary share award was approved by the board on April 22, 2026, subject to shareholder approval, and subsequently approved by shareholders at the Company’s September 9, 2026 annual general meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 05:00 PM Accepted by SEC EDGAR 09/11/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arkind Noam

(Last) (First) (Middle)

C/O ARBE ROBOTICS LTD.

HAHASHMONAIM ST. 107

(Street)

TEL AVIV 000000

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arbe Robotics Ltd. [ ARBE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/03/2026		S(2)		35,800	D	$0.6321	1,525,482	D
Ordinary Shares	09/04/2026		S(2)		22,700	D	$0.6294	1,502,782	D
Ordinary Shares	09/08/2026		S(2)		278,800	D	$0.7796	1,223,982	D
Restricted Shares	09/09/2026		A(1)		185,000	A	$0	1,408,982	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities are restricted ordinary shares granted under the Company's equity incentive plan. The shares vest in full on April 1, 2027, subject to the reporting person's continued service through the vesting date, and are subject to forfeiture until vesting. The award was approved by the Board on April 22, 2026, subject to shareholder approval, and was approved by the Company's shareholders at the annual general meeting held on September9, 2026.

2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2026.

	/s/ Noam Arkind	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)